By Wendy Van Sickle
Columbus, Ohio, April 22 – UBS AG, London Branch priced $4.1 million of trigger autocallable contingent yield notes due Feb. 27, 2025 linked to the least performing of the SPDR S&P Biotech ETF and the iShares MSCI Emerging Markets ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at the rate of 10.6% per year if each ETF closes at or above its coupon barrier, 70% of its initial level, on the related observation date.
The notes will be automatically called at par plus coupon if the shares of each ETF close at or above its initial share price on any quarterly call observation date after 12 months.
If the notes are not called and the final share price of each ETF is greater than or equal to the downside threshold level, 70% of the initial share price, the payout at maturity will be par plus the final coupon. Otherwise, investors will lose 1% for every 1% that the final share price of the least performing ETF is less than its initial share price.
UBS Investment Bank and UBS Financial Services Inc. are the agents.
Issuer: | UBS AG, London Branch
|
Issue: | Trigger autocallable contingent yield notes
|
Underlying ETFs: | SPDR S&P Biotech ETF, iShares MSCI Emerging Markets ETF
|
Amount: | $4.1 million
|
Maturity: | Feb. 27, 2025
|
Coupon: | 10.6% per year, paid quarterly, if each ETF closes at or above its coupon barrier on any related observation date
|
Price: | Par of $10
|
Payout at maturity: | Par plus final coupon unless any ETF finishes below downside threshold level, in which case 1% loss for each 1% decline of laggard ETF from initial level
|
Call: | Automatically at par plus coupon if each ETF closes at or above initial level on any quarterly call observation date after 12 months
|
Initial levels: | $85.10 for Biotech, $47.47 for MSCI Emerging Markets
|
Coupon barrier levels: | $59.57 for Biotech, $33.23 for MSCI Emerging Markets; 70% of initial levels
|
Downside thresholds: | $59.57 for Biotech, $33.23 for MSCI Emerging Markets; 70% of initial levels
|
Pricing date: | Feb. 23
|
Settlement date: | Feb. 28
|
Agents: | UBS Investment Bank and UBS Financial Services Inc.
|
Fees: | 3.5%
|
Cusip: | 90279DE44
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.